Wolkoff AW, Bhargava MM, Chung CT and Gatmaitan Z. Purification of ligandin by affinity chromatography on sulfobromophthalein-agarose gel. Proc. Soc. Exp. Med. Biol., 1979, 160:150.
Wolkoff AW and Chung CT. Identification, purification and partial characterization of an organic anion binding protein from rat liver cell plasma membrane. J Clin. Invest., 1980, 65:1152.
Hoffman PL, Chung CT and Tabakoff B. Effects of ethanol, temperature and endogenous regulatory factors on the characteristics of striatal opiate receptors. J Neurochem, 1984, 43:1003.
Chung CT, Tamarkin L, Hoffman PL and Tabakoff B. Ethanol enhancement of isoproterenol-stimulated melatonin and cyclic AMP release from cultured pineal glands. J Pharmacol. Exp. Ther., 1989, 249:16.
Miller RH, Kaneko S, Chung CT, Girones R and Purcell RH. Compact organization of the hepatitis B virus genome. Hepatology 1989, 9:322.
Chung CT and Miller RH. A rapid and convenient method for the preparation and storage of competent bacterial cells. Nucleic Acids Res. 1989, 16:3480.
Chung CT, Niemela SL and Miller RH. One step preparation of competent Escherichia coli cells: transformation and storage of bacterial cells in the same solution. Proc. Natl. Acad. Sci. USA, 1989, 86:2172.
Chung CT and Miller RH. Preparation and storage of competent Escherichia coli cells. Methods in Enzymology, 1993, 218:621.
Chung CT and Carlson RW. The role of aromatase inhibitors in early breast cancer. Curr Treat Options Oncol. 2003, 4(12):133.
Chung CT and Carlson RW. Goals and objectives in the management of metastatic breast cancer. Oncologist, 2003, 8(6):514.
Fiddler J. Chung CT and Rosen G. PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy. Mol Cancer Ther., 2003, 2:855.
Chung CT and Carlson RW. Adjuvant aromatase inhibitors following tamoxifen for early stage breast cancer in postmenopausal women: what do we really know? Clin Breast Cancer, 2004, 5(suppl1):S18-23.
Chung CT. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk (commentary). Women’s Oncology Review 2004; 4(4); 279-281.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Approved: 06/08.
